Program

 Download Program (PDF, 16MB)

 GSCN Conference 2013 Report (PDF, 2.6 MB)



Monday Tuesday  Wednesday


Monday, November 11th

12:00 – 13:00  Registration 
   
  Opening 
13:00 – 13:10 Welcome to the Max Delbrück Center:
Walter Rosenthal (Scientific Director, MDC) 
13:10 – 13:30  A Stem Cell Network for Germany - why the time is just right
Oliver Brüstle (Acting President, GSCN)

13:30 – 14:30   Keynote lecture I
K1 – Regenerative medicine by somatic stem cells: The paradigm of epithelial cells
Michele de Luca; Center for Regenerative Medicine “Stefano Ferrari”, Modena, Italy
(Chair: Frank Emmrich)
14:30 – 15:00  Coffee break / Industry Exhibition
15:00 – 16:00  Keynote lecture II 
K2 – In vivo phenotypic and functional stability of iDA neurons and chemo-genetic enhancement of their therapeutic potential
Vania Broccoli; San Raffaele Scientific Institute, Milan, Italy
(Chair: Mathias Treier)

16:00 – 16:30  Introduction of the GSCN strategic working groups 
16:30 – 19:00  Poster session I: P001 - P094
P001 – P019: Pluripotency and embryonic stem cells
P020 – P052: Programing and reprograming
P053 – P072: Stem cells in development
P073 – P081: Stem cells in tissues of neural and non-neural ectoderm
P082 – P094: Stem cells in tissues of meso- and endodermal origin 
19:00  Bus shuttle to event location
20:00 – 00:30 Networking evening with dinner buffet at eventlocation “Alte Pumpe”
Lützowstr. 42, 10785 Berlin (www.altepumpe.de)
(Opening: Albrecht Müller) (included in the registration fee)



Top 

Tuesday, November 12th

Concurrent scientific working group session I 

Axon 1*:  Pluripotency and embryonic stem cells
(chair:
Mathias Treier / James Adjave) 
09:30 – 09:40  Introduction 
09:40 – 10:00  T01 - Loss of Myc activity induces cellular dormancy in ES cells cultured in 2i mimicking the status of diapause embryos
Roberta Scognamiglio
; German Cancer Research Center, Heidelberg 
10:00 – 10:20  T02 - Epigenetic regulation of lineage commitment
Gunnar Schotta; Adolf Butenandt Institute, LMU Munich
10:20 – 10:40  T03 - Mll2 is the H3K4 trimethyltransferase for bivalent promoters in mouse embryonic stem cells
A. Francis Stewart
; Technical University Dresden 
10:40 – 11:00  Group discussion
   
Axon 2: Cancer stem cells in solid tumors
(chair: Andreas Trumpp / Thomas Brabletz)
09:30 – 09:40 Introduction
09:40 – 10:00 T04 - The KC/IL8-mTOR axis activates stem cell maintenance and chemotherapy resistance of hepatic tumor-initiating cells
Uta Kossatz-Böhlert; University Tübingen
10:00 – 10:20 T05 - The role of EVI1 in breast cancer cells
Hui Wang; University Hospital Basel, Switzerland
10:20 – 10:40 T06 - Patient derived models for pancreatic cancer reveal four molecular subtypes associated with differential drug response and clinical outcome
Elisa Noll; HI-STEM, Heidelberg
10:40 – 11:00 Group discussion
   
Dendrit 2/3: Stem cells in tissues of meso- and endodermal origin
(chair: Thomas Braun / Heiko Lickert)
09:30 – 09:40 Introduction 
09:40 – 10:00 T07 - A lentiviral RNAi screen against the muscle stem cell proteome identifies novel regulators governing muscle regeneration
Johnny Kim; MPI f. Heart and Lung Research, Bad Nauheim
10:00 – 10:20 T08 - Direct lineage conversion of liver to pancreas
Francesca M. Spagnoli; Max Delbrück Center, Berlin
10:20 – 10:40 T09 - Early Growth Response transcription factors Egr1 and Egr2 regulate lineage commitment of bone marrow mesenchymal stromal progenitors
Konstantinos Anastassiadis; BIOTEC, Technical University Dresden
10:40 – 11:00 Group discussion
   
11:00 – 11:30 Coffee break / Industry exhibition
 
Concurrent strategic working group session A
 
Axon 1:  Career development (chairs: Insa Schröder / NN)
11:30 – 11:50 I1 – Alternative career pathways for life scientists
Thorsten Abs; academics GmbH, Hamburg
11:50 – 12:30  Group / panel discussion
   
Axon 2:  Funding programs/policies (chairs: Albrecht Müller / Ulrich Martin)
11:30 – 11:50 I2 - Horizon 2020 - News on EU research funding
Jürgen Sautter; European Commission, Brussels, Belgium
11:50 – 12:30 Group / panel discussion
   
Dendrit 2/3:  Outreach activities and public perception of stem cell therapies (chair: Tobias Cantz / Ira Herrmann
11:30 – 11:40  Introduction (Tobias Cantz)
11:40 – 11:55  I3: EuroStemCell Toolkit for Public Engagement: Information, Education, Conversation
Emma Kemp, EuroStemCell, Edinburgh, United Kingdom
11:55 – 12:10 I4: Ethical aspects of innovative therapies
Gisela Badura-Lotter, University Ulm 
12:10 – 12:30  Group/panel discussion
   
12:30 – 13:30  Lunch buffet / Industry exhibition 
   
Concurrent strategic working group session B 
 
Axon 1:  Stem cell technologies (chair: Frank Emmrich / Andreas Bosio) 
13:30 – 13:50  I5: Stem cell technologies
Andreas Bosio; Miltenyi, Berg. Gladbach, and Frank Emmrich; University Leipzig 
13:50 – 14:30  Group/panel discussions 
   
Axon 2:  Clinical trials and regulatory affairs (chair: Torsten Tonn / Andreas Kurtz)
13:30 – 13:50  I6: Implementation of cell- and gene therapy for clinical application: challenges and regulatory requirements
Christine Günther; Apceth GmbH & Co. KG, Ottobrunn 
13:50 – 14:30  Group/panel discussions 
   
14:30 – 14:45  Short break 
   
Concurrent scientific working group session II 
 
Axon 1:  Stem cells in regenerative therapies (chair: Michael Cross / Ulrich Martin)
14:45 – 14:55  Introduction 
14:55 – 15:15  T10 - Transplantation of genetically corrected human iPSC-derived neural stem cells in a mouse model of metachromatic leukodystrophy
Jonas Doerr; Institute of Reconstructive Neurobiology, Bonn 
15:15 – 15:35 T11 - MicroRNA-199a-5p: A novel regulator of differentiation of hepatocytes from embryonic stem cells
Selina Möbus; REBIRTH, MH Hannover 
15:35 – 15:55  T12 - Successful treatment of therapy-refractory acute Graft-versus-Host disease with mesenchymal stem cell-derived exosomes
Bernd Giebel; Institute for Transfusion Medicine, Essen 
15:55 – 16:15
Group discussion 
   
Axon 2:  Programing and reprograming (chair: Micha Drukker / Frank Edenhofer) 
14:45 – 14:55  Introduction 
14:55 – 15:15  T13 - Analysis of signaling framework governing cardiac specification of human pluripotent stem cells
Boris Greber; MPI f. molecular Biomedicine, Münster 
15:15 – 15:35  T14 - Generation of mature megakaryocytes from human pluripotent stem cells by a transcription factor mediated forward programming approach 
Thomas Moreau; University of Cambridge, United Kingdom
15:35 – 15:55  T15 - A DNA methylation motifs discovery algorithm reveals the crosstalk among DNA methylation, transcription factors and histone marks in pluripotent cells
Marcos J. Arauzo-Bravo; MPI f. molecular Biomedicine, Münster
15:55 – 16:15  Group discussion
   
Dendrit 2/3:  Stem cells in tissues of neural and non-neural ectoderm (chair: Walter Birchmeier / Ana Martin-Villalba)
14:45 – 14:55  Introduction
14:55 – 15:15  T16 - Clonal lineage tracing of adult neural stem cells reveals features of adult neurogenesis
Filippo Calzolari; Helmholtz Center Munich 
15:15 – 15:35  T17 - The inflammatory gene AKNA, an at-hook containing transcription factor, regulates differentiation and survival of neural stem cells
Pia Johansson; Helmholtz Center Munich 
15:35 – 15:55  T18 - Oligodendrogenic and neurogenic adult subependymal zone neural stem cells constitute distinct lineages and exhibit differential responsiveness to Wnt
Benedikt Berninger; University Mainz  
15:55 – 16:15  Group discussion 
   
16:15 - 18:45  Poster session II: P095 – P193
P095 – P116: HSCs and stem cells in hematopoietic malignancies 
P117 – P128: Cancer stem cells in solid tumors 
P129 – P166: Stem cells in regenerative therapies 
P167 – P193: Stem cells in disease modeling and drug development 
18:45 – 19:30  Dinner buffet 
19:30 – 21:00  Convention of GSCN members 
21:00 – 22:00  Informal GSCN get-together (MDC.C Foyer)

Top 

Wednesday, November 13th

Concurrent scientific working group session III 
 
Axon 1:  Stem cells in disease modeling and drug development (chair: Karl-Ludwig Laugwitz / Oliver Brüstle) 
09:00 – 09:10  Introduction 
09:10 – 09:30  T19 - Induction of nuclear ataxin-3 inclusions in Machado-Joseph disease-specific neurons
Johannes Jungverdorben (Inst. of Reconstructive Neurobiology, Bonn) 
09:30 – 09:50  T20 - Restoration of GM-CSF depended functionalities in macrophages utilizing patient specific iPSC from a congenital pulmonary alveolar proteinosis patient
Nico Lachmann (MHH, Hannover) 
09:50 – 10:10  T21 - Raman spectroscopy as novel marker for sensitive stem cell identification
Karin Schütze (CellTool GmbH, Bernried) 
10:10 – 10:30  Group discussion
   
Axon 2:  Stem cells in development (chair: Elly Tanaka / Jan Lohmann) 
09:00 – 09:10  Introduction 
09:10 – 09:30  T22 - Tet-dependent processing of 5-methylcytosine, epigenetic stability and the maintenance of active higher order structures during differentiation
Achim Breiling (German Cancer Research Center, Heidelberg) 
09:30 – 09:50  T23 - Aldh1b1 regulates the timing in pancreas lineage segregation and beta cell maturation
Elpinki Ninou (Paul Langerhans Institute, Dresden) 
09:50 – 10:10  T24 - A transitional extracellular matrix instructs regenerative cell behavior
Hans-Georg Simon (Northwestern University, Chicago) 
10:10 – 10:30  Group discussion 
   
Dendrit 2/3:  HSCs and stem cells in hematopoietic malignancies (chair: Anthony Ho / Timm Schröder) 
09:00 – 09:10  Introduction 
09:10 – 09:30  T25 - The genome wide molecular landscape of hematopoietic stem cells and their immediate progeny
Nina Cabezas-Wallscheid (DKFZ, Heidelberg) 
09:30 – 09:50  T26 - Crosstalk between WNT/β-catenin and IRF8 in hematopoiesis and leukemia
Marina Scheller (UKE, Hamburg) 
09:50 – 10:10  T27 - A stem cell intrinsic switch from canonical to non-canonical Wnt signaling regulates aging of hematopoietic stem cells
Maria Carolina Florian (University Ulm) 
10:10 – 10:30  Group discussion 
   
10:30 – 11:00  Coffee break / Industry exhibition 
   
Industry session: “Technologies from GSCN industry partners” 
   
Axon 1:  Main supporters 
11:00 – 11:05  Introduction (Mathias Treier) 
11:05 – 11:35  C1 - Development of a new serum-free media for the cultivation of pluripotent stem cells
Bärbel Icheln, Peprotech GmbH 
11:35 – 12:05   C2 - Novel reagents for pluripotent stem cell research and differentiation to neural lineages
Mohan C. Vemuri, Life Technologies GmbH 
12:05 – 12:35  C3 - Gene expression analysis down to the single cell level by digital quantification utilizing the nCounter system 
Maik Prüß; Nanostring Tech. LTD 
   
Axon 2:  Supporters 
11:00 – 11:05  Introduction (Ulrich Martin) 
11:05 – 11:35  C4 – Flow cytometry applications for isolating and analyzing complex heterogeneous stem cell cultures
Yannick Marari, BD Biosciences 
11:35 – 12:05  C5 - Suspension culture and cardiomyogenic differentiation of human pluripotent stem cells in stirred bioreactor systems
Robert Zweigerdt, MH Hannover, representing Eppendorf AG 
12:05 – 12:35  C6 - Pharmaceutical stem cell therapy for advanced diseases entering clinical application
Veronika Reiter, Apceth GmbH & Co. KG 
   
Dendrit 2/3:  Supporters 
11:00 – 11:05  Introduction (Michael Cross) 
11:05 – 11:35  C7 – Discover a New Approach to Single-Cell Genomics with the C1™ Single-Cell Auto Prep System
Fluidigm, Europe B.V. 
11:35 – 12:05  C8 - The IncuCyte system - new applications for iPSC production
Peter K. Djali, Essen BioScience Ltd. 
12:05 – 12:35   C9 - Development of extracellular matrices for stem cell culture
Maja Petkovic, AMS Biotechnology (Europe) Limited  
   
12:35 – 14:00  Lunch buffet / industry exhibition
   
14:00 – 15:00  Keynote lecture III 
  K3 - Cardiomyocytes from human pluripotent stem cells: the new patient in safety pharmacology, drug discovery and disease
Christine Mummery; Leiden University Medical Center, Netherlands
(Chair: Andreas Trumpp)
 
15:00 – 15:30  Coffee break / industry exhibition 
   
15:30 – 16:30  EMBO Lecture 
  K4 - Design principles of pluripotency 
Austin Smith; Wellcome Trust-MRC Stem Cell Institute, University of Cambridge, United Kingdom
(Chair: Oliver Brüstle)
   
  Closing ceremony 
16:30 – 16:45  Poster award ceremony (Daniel Besser, GSCN) 
16:45 – 17:00  Outlook and closing remarks
Andreas Trumpp (Incoming president, GSCN)
Top 
Kontaktdaten
German Stem Cell Network (GSCN)
c/o Charité Universitätsmedizin
Luisenstr. 65
10117 Berlin

Supporters